Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
- PMID: 18284364
- DOI: 10.1086/524745
Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
Abstract
Ten ischemic cardiac events (ICEs) were reported among 37,901 initial US Department of Health and Human Services (DHHS) smallpox vaccinees. Symptoms developed a median of 10 days after vaccination (range, 0-28 days). The median age of case patients was 56 years (range, 42-65 years), and 60% were male. Seven (70%) of the case patients had >/=3 cardiac risk factors or probable coronary artery disease before vaccination. Two women, 55 and 57 years of age, experienced acute myocardial infarction and fatal cardiac arrests. Background rates of ICEs during a 3-week period for civilian populations that were age and sex matched to DHHS vaccinees were estimated. The observed number of myocardial infarctions exceeded estimated expectations (5 vs. 2) but remained within the 95% predictive interval (PI) (0.6-5.4). New onset angina was observed significantly less frequently than estimated expectations (1 vs. 10; 95% PI, 3.5-15.7). After persons with >/=3 cardiac risk factors or known heart disease were deferred from vaccination, no ICEs were reported among an additional 6638 vaccinees.
Similar articles
-
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S258-70. doi: 10.1086/524749. Clin Infect Dis. 2008. PMID: 18284367
-
Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003.Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S242-50. doi: 10.1086/524747. Clin Infect Dis. 2008. PMID: 18284365
-
The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program.Vaccine. 2005 Mar 18;23(17-18):2078-81. doi: 10.1016/j.vaccine.2005.01.012. Vaccine. 2005. PMID: 15755574 Review.
-
Smallpox vaccination and myopericarditis: a clinical review.J Am Coll Cardiol. 2004 May 5;43(9):1503-10. doi: 10.1016/j.jacc.2003.11.053. J Am Coll Cardiol. 2004. PMID: 15120802 Review.
-
Update: cardiac-related events during the civilian smallpox vaccination program--United States, 2003.MMWR Morb Mortal Wkly Rep. 2003 May 30;52(21):492-6. MMWR Morb Mortal Wkly Rep. 2003. PMID: 12809110
Cited by
-
Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18. Vaccine. 2014. PMID: 24951868 Free PMC article.
-
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.J Infect Dis. 2013 Jun 15;207(12):1888-97. doi: 10.1093/infdis/jit105. Epub 2013 Mar 12. J Infect Dis. 2013. PMID: 23482644 Free PMC article. Clinical Trial.
-
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Expert Rev Vaccines. 2011 Aug;10(8):1221-40. doi: 10.1586/erv.11.79. Expert Rev Vaccines. 2011. PMID: 21854314 Free PMC article. Review.
-
ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Drug Des Devel Ther. 2010 May 25;4:71-9. doi: 10.2147/dddt.s3687. Drug Des Devel Ther. 2010. PMID: 20531961 Free PMC article. Review.
-
Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.J Virol. 2009 Jan;83(2):1115-25. doi: 10.1128/JVI.00984-08. Epub 2008 Nov 12. J Virol. 2009. PMID: 19004937 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous